Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueReturn on AssetsReturn on Sales

Mainz Biomed (MYNZ) EBIT Margin (2022 - 2023)

Historic EBIT Margin for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to 3068.71%.

  • Mainz Biomed's EBIT Margin rose 12715900.0% to 3068.71% in Q4 2023 from the same period last year, while for Dec 2023 it was 2975.47%, marking a year-over-year increase of 20151300.0%. This contributed to the annual value of 2091.23% for FY2024, which is 8842400.0% up from last year.
  • According to the latest figures from Q4 2023, Mainz Biomed's EBIT Margin is 3068.71%, which was up 12715900.0% from 3104.9% recorded in Q3 2023.
  • Over the past 5 years, Mainz Biomed's EBIT Margin peaked at 2593.94% during Q1 2023, and registered a low of 5657.13% during Q3 2022.